The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A mechanistic role for cardiac myocyte apoptosis in heart failure
Open accessAbstract
Heart failure is a common, lethal condition whose pathogenesis is poorly understood. Recent studies have identified low levels of myocyte apoptosis (80-250 myocytes per 10(5) nuclei) in failing human hearts. It remains unclear, however, whether this cell death is a coincidental finding, a protective process, or a causal component in pathogenesis. Using transgenic mice that express a conditionally active caspase exclusively in the myocardium, we demonstrate that very low levels of myocyte apoptosis (23 myocytes per 10(5) nuclei, compared with 1.5 myocytes per 10(5) nuclei in controls) are sufficient to cause a lethal, dilated cardiomyopathy. Interestingly, these levels are four- to tenfold lower than those observed in failing human hearts. Conversely, inhibition of cardiac myocyte death in this murine model largely prevents the development of cardiac dilation and contractile dysfunction, the hallmarks of heart failure. To our knowledge, these data provide the first direct evidence that myocyte apoptosis may be a causal mechanism of heart failure, and they suggest that inhibition of this cell death process may constitute the basis for novel therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, inhibiting caspases can both reduce the occurrence of heart failure or slow its progression after MI (45, 131, 374, 383, 384) as well as improve contractile function (45).”
From Cardiac remodeling in obesity (2008) · cites this paper as [374]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thornberry, N. A., & Lazebnik, Y. A. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,857
Apoptosis in the Failing Human Heart
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361603 · Cited by 1,673
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631
Apoptosis in Myocytes in End-Stage Heart Failure
Narula, J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W., & Khaw, B.-A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351603 · Cited by 1,430
Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C. G., McDowell, J., Paskind, M. P., Rodman, L., Salfeld, J. G., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90490-5 · Cited by 1,408
Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme
Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M. A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., et al. (1997) · Science · doi:10.1126/science.275.5297.206 · Cited by 1,159
An Induced Proximity Model for Caspase-8 Activation
Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., & Dixit, V. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2926 · Cited by 1,023
Caspase activation: The induced-proximity model
Salvesen, G. S., & Dixit, V. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.10964 · Cited by 932
Controlling Signal Transduction with Synthetic Ligands
Spencer, D. M., Wandless, T. J., Schreiber, S. L., & Crabtree, G. R. (1993) · Science · doi:10.1126/science.7694365 · Cited by 845
Luo, W., Grupp, I. L., Harrer, J. M., Ponniah, S., Grupp, G., Duffy, J. J., Doetschman, T., & Kranias, E. G. (1994) · Circulation Research · doi:10.1161/01.res.75.3.401 · Cited by 706
Flagged first, then by citations
Research works printed but not linked: 2
- Walter, 1989, Biotechniques., 7, 1065
- Li, 1997, Am. J. Physiol., 272, H2313
Cited by
Sorted by citations
Items 701–765 of 765
Meyer, G. R. Y. D., Schrijvers, D. M., & Martinet, W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0268-2_22
cardiomyocyte necrosis as a primary mediator of heart failure
Nakayama, H., Chen, X., Baines, C. P., Klevitsky, R., Zhang, X., Zhang, H., Jaleel, N., Hewett, T. E., Robbins, J. M., Houser, S. R., et al. (2007)
Sundararaman, S. (2010) · EngagedScholarship @ Cleveland State University (Cleveland State University)
Update in physiopathological mechanisms in heart failure
Ulate-Montero, G., & Ulate-Campos, A. (2008) · Acta Médica Costarricense
Heart Failure in the Era of Genomic Medicine
Benjamin, I. J., & Patel, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374934-5.00026-x
Jiang, Q. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
Gene Therapy for Heart Failure
Foo, S. Y., & Rosenzweig, A. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420020168.031
Human Stem Cell‐Derived CardiomyocyteIn VitroModels for Cardiotoxicity Screening
Walker, T. M., Harris, K. L., Maifoshie, E., & Chaudhary, K. W. (2016) · Wiley eBooks · doi:10.1002/9781119135449.ch6
CARDIOVASCULAR EFFECTS OF ORAL CALCIUM SENSITIZERS ON EXPERIMENTAL HEART FAILURE
Louhelainen, M. (2010)
Lefnaier, W. (2017) · uO Research (University of Ottawa) · doi:10.20381/ruor-670
Favarato, D., & Gutierrez, P. S. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170058
Blackburn, N. J. (2017) · uO Research (University of Ottawa) · doi:10.20381/ruor-20651
Xie, Z., Tian, J., Cooper, C. J., Shapiro, J. I., Lingrel, J. B., Liu, L., Bai, Y., & Chen, Y. (2013)
Causes of Elevated Troponin in Patients with Normal Coronary Angiography
Reschner, A., Strozzi, M., Miovski, Z., Bešić, K. M., & Bulum, J. (2019) · Cardiologia Croatica · doi:10.15836/ccar2019.159
Goldswain, T. L. (2017) · SUNScholar (Stellenbosch University)
A Critical Therapeutic Target to Inhibit Apoptosis in Relevant Heart Failure: An Overview
Nepala, A., Yasmeenb, S., Akhtarc, F., Kojua, N., Aina, Q. U., Teng-Li, C., Xiu-Xiua, Z., Qinga, L., & Ding-Dinga, C. (2018) · American Journal of Advanced Drug Delivery · doi:10.21767/2321-547x.1000027
Pourrazi, H., & Jafari, A. (2019) · Nutrition and Food Sciences Research · doi:10.29252/nfsr.6.2.13
The role of MAP4K4 in cardiac muscle cell death
Jenkins, M. (2018) · Spiral (Imperial College London) · doi:10.25560/62638
小鼠心脏过表达SIRT1显性失活突变体导致心肌细胞凋亡和早发性心衰
鲁, 云., 郑, 伟., 陈, 厚., 穆, 文., 折, 志., 刘, 德., 韦, 玉., 付, 文., 唐, 小., 李, 红., et al. (2014) · Scientia Sinica Vitae · doi:10.1360/zc2014-44-9-861
Heart Failure in the Era of Genomic Medicine
Benjamin, I. J., & Patel, J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369420-1.00059-7
Farahzadi, R., Fathi, E., Vietor, I., & Javanmardi, S. (2020) · doi:10.21203/rs.3.rs-21094/v1
Jahani, M., Homaie, H. M., & Farzanegi, P. (2020) · journal of ilam university of medical sciences · doi:10.29252/sjimu.28.5.53
D’Souza, A. (2011) · CLOK (University of Central Lancashire)
Chun, B., Ngo, L., & Saucerman, J. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.17.435783
Federico, M. (2021) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/115958
Kelm, N. Q. (2015) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2227
Doxorubicin induces delayed heart and liver mitochondrial depolarisation
Mańdziuk, S., Bis, L., Bury, K., Korga-Plewko, A., Burdan, F., & Dudka, J. (2015) · Current Issues in Pharmacy and Medical Sciences · doi:10.12923/j.2084-980x/26.1/a.04
Molecular and Cellular Events in Myocardial Hypertrophy and Failure
Sawyer, D. B., & Colucci, W. S. (2005) · doi:10.1007/978-1-4757-4558-0_4
(2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.12.022
Apoptosis-Related Diseases and Peroxisomes
Wang, M., Liu, Y., Chen, N., Wang, J., & Zhao, Y. (2022) · Physiology · doi:10.5772/intechopen.105052
Starvation Induces Diverse Autophagic Response in Cardiomyocytes and NoncardiomyocytesPreprint
He, X., Huang, H., Wu, Y., & Guo, F. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.10.495581
Földes, G., Lyon, A. R., & Harding, S. E. (2022) · doi:10.1093/med/9780198766223.003.0017
Protective effect of Esculetin on myocardial injury induced by doxorubicin
Xu, F., Li, X., & Yu, X. (2022) · Nepalese Journal of Cancer · doi:10.3126/njc.v6i2.48773
Astani, K., Bashiri, J., Pourrazi, H., & Nourazar, M. A. (2022) · Bimonthly Journal of Hormozgan University of Medical Sciences · doi:10.34172/hmj.2022.12
Liu, Q., Huang, J., Ding, H., Tao, Y., Xiao, C., Wang, Y., Wu, R., Ni, C., Zhong, Z., Zhu, W. M., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3026904/v1
Right Ventricle and Functional Tricuspid Regurgitation: An Unpredictable Interaction
Mauro, M. D., Iaco, A. L., Own, A., Clemente, D., & Calafiore, A. M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6488-3_19
Sun, J., Wang, Z., Zheng, C., Duan, Y., Liu, C., Zhao, S., & Deng, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3321598/v1
Long noncoding RNAs and miRNAs
Duttaroy, A. K., & Mallick, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99570-2.00013-8
Oxidative Stress and Heart Failure
Chen, Q. M., Morissey, S., & Alpert, J. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00086-3
Role of Apoptosis in Cardiovascular Diseases: Therapeutic Targets and Strategies
Kar, A., Mitra, A., & Sarkar, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-7905-5_13
Chang, M., Meng, J., Liu, G., & Shi, C. (2025) · Molecular & Cellular Toxicology · doi:10.1007/s13273-025-00543-0
Borrelia infection as an important risk factor for severe coronary heart disease
Bondarenko, A. L., Tarlovskaya, E. I., Жолобова, Т. В., Bondarenko, A. L., Tarlovskaya, E. I., & Жолобова, Т. В. (2011) · Epidemiology and Infectious Diseases · doi:10.17816/eid40550
Chun, B., Ngo, L., & Saucerman, J. J. (2025) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2025.100484
Bourke, L. (2014) · UCL Discovery (University College London)
Senger, F., Hille, S. S., Remes, A. K., Baral, T. K., Martín-Garrido, A., Schmiedel, N., Kühn, C., Müller, O. J., Rangrez, A. Y., Backs, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.17.712297
Short-term intermittent hypoxia induces biphasic apoptotic responses in the murine heart
Arbatlı, S., & Peker, Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-45151-7
Renaud-Gabardos, E. (2016) · theses.fr (ABES) · doi:10.70675/6d9b4309za1adz4f4aza374zddc5391a757f
Thérapie génique de l'insuffisance cardiaque par les phosphodiestérases
Bourcier, A. (2019) · theses.fr (ABES) · doi:10.70675/19ee12d6z21e8z440fza3cfz9b22674b5d02
Le rôle de la galanine dans le remodelage cardiaque
Timotin, A. (2017) · theses.fr (ABES) · doi:10.70675/32f3b46bzd7a8z4dacz9ba8z6c9e89e61682
Target and small molecule discovery for therapeutic innovation in cardiovascular area
Liu, D. (2019) · theses.fr (ABES) · doi:10.70675/da9fa152zdcc0z498dz9194z563d22d0b77c
Xi, Y., Kuempel, J., Choi, S., DeSpain, P. S., Zhang, T., Zhu, J., Osborn, A., Rivera, R. A., Zhong, S., Wu, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.02.716218
Multicellular senescence programs in the aged heart
Bultot, L., Tsurudome, N., Kumazaki, E., & Shimizu, I. (2026) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2026.100852
ERBB4 deficiency promotes atrial myopathy underlying the atrial fibrillation substratePreprint
Yamaguchi, N., Santucci, J., Hong, S. J., Ferrena, A., Schlamp, F., Willett, D. K., Casdin, C. J., Park, P. S., Lin, X., Xiao, J., et al. (2026) · medRxiv · doi:10.64898/2026.05.26.26354173
Icariside Ⅱ alleviates heart failure based on Wnt/β-catenin-mitochondrial apoptotic pathway
Zhu, J., Tang, W., Huang, D., Sun, L., Wang, Y., & Yang, D. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179099
Badr, S. N., Hussein, M. A., Eltamany, E. H. M., Mostafa, N. Y., & Abbas, A. O. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10856-9
Clinical landscape of human pluripotent stem cell-derived cardiomyocyte therapy
Mui, B. W. H., Neofytou, E. A., & Wu, J. C. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102962
El‐Sabbagh, W. A., Fadel, N. A., Sanad, E. F., El-Bakly, W., & Said, R. S. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05919-0
Metadata
- Authors
- Wencker, D., Chandra, M., Nguyen, K., Miao, W., Garantziotis, S., Factor, S. M., Shirani, J., Armstrong, R. C., & Kitsis, R. N.
- Affiliations
- Albert Einstein College of Medicine (US)
- Yeshiva University (US)
- Pfizer (United States) (US)
- Corresponding author
- Kitsis, Richard N.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-05-15
- Volume
- 111
- Issue
- 10
- Pages
- 1497-1504
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC155051
- OpenAlex
- W2002958873
- Cited by
- 765
- References
- 29
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 27 · 2023: 18 · 2022: 31 · 2021: 18 · 2020: 31 · 2019: 23 · 2018: 28 · 2017: 32 · 2016: 35 · 2015: 28 · 2014: 45 · 2013: 30 · 2012: 42
- FWCI
- 32.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ariad Pharmaceuticals
- New York Academy of Medicine
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01-HL-61550, R01 HL-60665, R01HL061550, R01HL060665)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Keywords
- cardiomyocyte apoptosis, heart failure, dilated cardiomyopathy, caspases, transgenic mice, myocardial cell death, contractile dysfunction, heart failure pathogenesis
- MeSH terms
- Animals, Disease Models, Animal, Enzyme Activation, Heart Failure, Humans, Mice, Inbred C57BL, Mice, Transgenic, Myocardium, Organ Specificity, Recombinant Fusion Proteins, Tacrolimus, Apoptosis, Disease Progression, Transgenes, Dimerization, Caspases, Enzyme Activators, Tacrolimus Binding Proteins, Myocytes, Cardiac, Mice, Caspase 8, Caspase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review